Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Abstract

Erythromycin suppresses the expression of cyclooxygenase-2 in rheumatoid synovial cells.

Takehide Fumimori, Seiyo Honda, Kiyoshi Migita, Minako Hamada, Taro Yoshimuta, Junichi Honda, Takaaki Fukuda, Ritsu Suzuki, Masafumi Gotoh, Katsumi Eguchi and Hisamichi Aizawa
The Journal of Rheumatology March 2004, 31 (3) 436-441;
Takehide Fumimori
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seiyo Honda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kiyoshi Migita
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Minako Hamada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Taro Yoshimuta
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Junichi Honda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takaaki Fukuda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ritsu Suzuki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masafumi Gotoh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katsumi Eguchi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hisamichi Aizawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

Abstract

OBJECTIVE: To investigate whether erythromycin (EM) can suppress the expression of cyclooxygenase-2 (COX-2) in rheumatoid synovial cells, and determine the mechanisms involved. Methods. Synovial tissues were obtained from 25 patients with rheumatoid arthritis (RA). Rheumatoid synovial cells were cultured with or without EM (0.1-1000 nM) in the presence of interleukin 1beta (IL-1beta) for various times. Protein expression of COX-2, and phosphorylation of extracellular signal regulated kinase 1/2 (ERK1/2) and p38 mitogen-activated protein kinase (p38 MAPK) were detected by Western blot. COX-2 messenger RNA (mRNA) was detected by RT-PCR. DNA binding activity of nuclear factor kappa B (NF-kB) was detected by ELISA. Results. IL-1beta-stimulated synovial cells expressed COX-2 protein. EM suppressed the IL-1beta-induced COX-2 protein expression in a dose-dependent manner and inhibited IL-1beta-induced p38 MAPK phosphorylation, which was correlated with COX-2 expression in synovial cells. In contrast, EM had no effect on DNA binding activity of NF-kB and ERK1/2 expression. CONCLUSION: Our results indicated that EM downregulated COX-2 expression by inhibiting the p38 MAPK cascade, but had no effect on NF-kB or ERK1/2, in rheumatoid synovial cells.

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 31, Issue 3
1 Mar 2004
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Erythromycin suppresses the expression of cyclooxygenase-2 in rheumatoid synovial cells.
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Erythromycin suppresses the expression of cyclooxygenase-2 in rheumatoid synovial cells.
Takehide Fumimori, Seiyo Honda, Kiyoshi Migita, Minako Hamada, Taro Yoshimuta, Junichi Honda, Takaaki Fukuda, Ritsu Suzuki, Masafumi Gotoh, Katsumi Eguchi, Hisamichi Aizawa
The Journal of Rheumatology Mar 2004, 31 (3) 436-441;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Erythromycin suppresses the expression of cyclooxygenase-2 in rheumatoid synovial cells.
Takehide Fumimori, Seiyo Honda, Kiyoshi Migita, Minako Hamada, Taro Yoshimuta, Junichi Honda, Takaaki Fukuda, Ritsu Suzuki, Masafumi Gotoh, Katsumi Eguchi, Hisamichi Aizawa
The Journal of Rheumatology Mar 2004, 31 (3) 436-441;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • References
  • PDF
  • eLetters

Related Articles

Cited By...

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire